Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 7/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | PRCP | P42785 | 1/20 | 0.36 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23410328 | 1.00 | CNR1 (0.43) | CNR1MEN1KMT2AATMCNR2 | |
| SCHEMBL23410885 | 0.78 | PTGDR2 (0.43) | CNR1MEN1KMT2AATMCNR2 | |
| SCHEMBL24407523 | 0.76 | KDM4A (0.35) | CNR1CNR2 | |
| SCHEMBL29655507 | 0.76 | KDM4A (0.35) | CNR1CNR2 | |
| SCHEMBL23411458 | 0.75 | CNR1 (0.43) | CNR1MEN1KMT2AATMPRCP | |
| SCHEMBL23421466 | 0.75 | CNR1 (0.40) | CNR1MEN1KMT2AATMLMNA | |
| SCHEMBL29635052 | 0.74 | MALT1 (0.44) | CNR1LMNAP2RX7 | |
| SCHEMBL30609050 | 0.74 | CNR1 (0.40) | CNR1MEN1KMT2AATMCNR2 | |
| SCHEMBL23447081 | 0.74 | MALT1 (0.44) | CNR1LMNAP2RX7 | |
| SCHEMBL1074268 | 0.70 | IDO1 (0.49) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12583826-B2 | [(1,5-diphenyl-1H-1,2,4-triazol-3-yl)oxy]acetic acid derivatives and salts thereof, crop protection compositions comprising them, methods for producing them and use thereof as safeners | BAYER AKTIENGESELLSCHAFT (DE) | 2026-03-24 | — | — | US | disclosed |
| CN-114728915-B | [ (1, 5-Diphenyl-1H-1, 2, 4-triazol-3-yl) oxy ] acetic acid derivatives and salts thereof, crop protection compositions containing same, method for producing same, and use thereof as safeners | 拜耳公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-116761510-A | Use of [ (1, 5-diphenyl-1H-pyrazol-3-yl) oxy ] acetic acid derivatives and salts thereof and compositions containing them for reducing the phytotoxic effect of agrochemicals, in particular herbicides, on useful plants and crops | 拜耳公司 | 2023-09-15 | — | — | CN | disclosed |
| US-20220388971-A1 | [(1,5-DIPHENYL-1H-1,2,4-TRIAZOL-3-YL)OXY]ACETIC ACID DERIVATIVES AND SALTS THEREOF, CROP PROTECTION COMPOSITIONS COMPRISING THEM, METHODS FOR PRODUCING THEM AND USE THEREOF AS SAFENERS | BAYER AKTIENGESELLSCHAFT (DE) | 2022-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12583826-B2 | [(1,5-diphenyl-1H-1,2,4-triazol-3-yl)oxy]acetic acid derivatives and salts thereof, crop protection compositions comprising them, methods for producing them and use thereof as safeners | CBR3, CBR1, HACL2 | CNR1 155/4885MEN1 4726/4885KMT2A 3535/4885 |
| US-20220388971-A1 | [(1,5-DIPHENYL-1H-1,2,4-TRIAZOL-3-YL)OXY]ACETIC ACID DERIVATIVES AND SALTS THEREOF, CROP PROTECTION COMPOSITIONS COMPRISING THEM, METHODS FOR PRODUCING THEM AND USE THEREOF AS SAFENERS | CYP4Z1, GSTO1, AADAC | CNR1 2315/4885MEN1 4721/4885KMT2A 2963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.